Fibroblast Growth Factor-23 and Vitamin D Metabolism in Subjects with eGFR ≥60 ml/min/1.73 m2

Publisher： Karger

E-ISSN： 2235-3186|130|2|119-126

ISSN： 1660-8151

Source： Nephron, Vol.130, Iss.2, 2015-06, pp. : 119-126

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fibroblast Growth Factor 23 in Chronic Kidney Disease: Bridging the Gap between Bone Mineral Metabolism and Left Ventricular Hypertrophy

By  

Blood Purification, Vol. 31, Iss. 1-3, 2010-12 ,pp. : 26-32

Karger

Access to resources Recommend Favorite

Serum Klotho: Relation to Fibroblast Growth Factor-23 and Other Regulators of Phosphate Metabolism in Children with Chronic Kidney Disease

By  

Nephron, Vol. 129, Iss. 4, 2015-03 ,pp. : 293-299

Karger

Access to resources Recommend Favorite

Albuminuria Is the Stronger Risk Factor for Peripheral Arterial Disease than eGFR Decline in a Type 2 Diabetic Taiwanese Population

By  

Kidney and Blood Pressure Research, Vol. 33, Iss. 5, 2010-08 ,pp. : 352-359

Karger

Access to resources Recommend Favorite

Analysis of α-Klotho, Fibroblast Growth Factor-, Vitamin-D and Calcium-Sensing Receptor in 70 Patients with Secondary Hyperparathyroidism

By  

Kidney and Blood Pressure Research, Vol. 37, Iss. 1, 2013-03 ,pp. : 84-94

Karger

Access to resources Recommend Favorite

Fibroblast Growth Factor 23 and Vascular Calcification: Is It Set in Stone?

By  

American Journal of Nephrology, Vol. 42, Iss. 6, 2015-0 ,pp. : 389-390

Karger

Access to resources Recommend Favorite